Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity

Virology
Marta Gómez-GonzaloManuel López-Cabrera

Abstract

Hepatitis C virus (HCV) core is a viral structural protein; it also participates in some cellular processes, including transcriptional regulation. However, the mechanisms of core-mediated transcriptional regulation remain poorly understood. Oncogenic virus proteins often target p300/CBP, a known co-activator of a wide variety of transcription factors, to regulate the expression of cellular and viral genes. Here we demonstrate, for the first time, that HCV core protein interacts with p300/CBP and enhances both its acetyl-transferase and transcriptional activities. In addition, we demonstrate that nuclear core protein activates the NH2-terminal transcription activation domain (TAD) of NF-AT1 in a p300/CBP-dependent manner. We propose a model in which core protein regulates the co-activation function of p300/CBP and activates NF-AT1, and probably other p300/CBP-regulated transcription factors, by a novel mechanism involving the regulation of the acetylation state of histones and/or components of the transcriptional machinery.

References

Apr 1, 1988·Molecular and Cellular Biology·D B DurandG R Crabtree
Dec 15, 1994·Biochemical and Biophysical Research Communications·S C ChangM F Chang
Jul 1, 1996·The Journal of Experimental Medicine·C LuoA Rao
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·G BarbaC Bréchot
May 1, 1997·Molecular and Cellular Biology·L LyakhN R Rice
Jan 1, 1997·Annual Review of Immunology·A RaoP G Hogan
Jun 17, 1998·Journal of Virology·K YasuiM Kohara
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A SabileG Barba
Oct 12, 1999·Intervirology·R SuzukiT Miyamura
Feb 17, 2000·The EMBO Journal·M A Martínez-BalbásT Kouzarides
Aug 1, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N KatoM Omata
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Takeya TsutsumiTatsuo Miyamura
May 22, 2002·The Journal of Biological Chemistry·Belén San-AntonioManuel Fresno
Jun 12, 2002·Biochemical and Biophysical Research Communications·Takayuki YamanakaTakefumi Doi
Jun 12, 2002·Biochemical and Biophysical Research Communications·Takayuki YamanakaTakefumi Doi
May 16, 2003·Molecular and Cellular Biology·Fang ZhaoTom Kadesch

❮ Previous
Next ❯

Citations

Jan 12, 2008·The Journal of Clinical Investigation·Naoki TanakaToshifumi Aoyama
Oct 15, 2010·Expert Opinion on Therapeutic Targets·Matthew W LawlessSteven G Gray
Mar 15, 2014·Virulence·Urania GeorgopoulouAvgi Mamalaki
Oct 25, 2006·Biochimica Et Biophysica Acta·Mounia ChamiPatrizia Paterlini-Bréchot
Sep 10, 2014·Journal of Human Evolution·Carlos LorenzoJosé María Bermúdez de Castro
Feb 22, 2007·Proceedings. Biological Sciences·Markus BastirAntonio Rosas
Feb 6, 2021·Journal of Clinical Medicine·Tom Domovitz, Meital Gal-Tanamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.